Several drugs have been studied, but none have demonstrated significant benefits, indicating a need for larger, well-designed, controlled trials
doi: 10.1093/nar/gkae973 Summary Keywords atheroscelrosis, cholesterol metabolism, acetyl-L-carnitine (ALC), SREBP2, HMGCR Citation Xing J, Du Z, Li F, Wang Y, Zhang Z, Gao X, Han L, Sun X, Sun H, Du Y, Hu C, Yu H and Qin Y (2024) Acetyl-L-carnitine ameliorates atherosclerosis in LDLR / mice by modulating cholesterol metabolism through SREBP2-dependent cholesterol biosynthesis
However, other research suggests that it does not provide any benefits
TangMZengYPengWXieXYangYJiBet al
Briefly, the fundamental pathology of ARHL is the degeneration of the auditory system
Under clinical investigation for obesity and metabolic dysfunction